Multicenter study of Kampo treatment for frailty in aged patients

Multicenter study of Kampo treatment for frailty in aged patients - Multicenter study of Kampo treatment for frailty in aged patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031859

Enrollment

Registered

2018-03-23

Start date

2017-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Interventions

Ninjinyoeito Administered orally at a dose of 7.5 g/day in two or three divided doses before or between meals. Adjust the dose as needed according to the age, body weight and symptoms of patients. T

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who meet a criterion for frailty 2)ambulatory patients

Exclusion criteria

Exclusion criteria: 1)Patients who have taken crude drug product within 2 weeks before enrollment 2)Patients suspected of having dementia (MMSE score 23 or below) 3)Patients with a history of Parkinson disease or stroke 4)Patients with serious complications (e.g., hepatic or cardiac diseases) 5)Other patients who are assessed to be inappropriate for study participation by the investigator, or other relevant persons

Design outcomes

Primary

Measure	Time frame
Number of steps and physical activity	—

Countries

Japan

Contacts

Public ContactHaruka Amitani

Kagoshima University Graduate School of Medical and Dental Sciences Department of Psychosomatic Internal Medicine

amitani@m3.kufm.kagoshima-u.ac.jp099-275-5751

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026